Radiotherapy plus camrelizumab and irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial
| Autor: | Zhao, Wensi, Ke, Shaobo, Cai, Xiaojun, Zuo, Zhigang, Shi, Wei, Qiu, Hu, Cai, Gaoke, Gong, Yi, Wu, Yong, Ruan, Shasha, Chen, Yongshun |
|---|---|
| Zdroj: | In Radiotherapy and Oncology July 2023 184 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect